Antiviral Therapy Plan & Monitoring â€“ valganciclovir dosing
Encounter: 10 | Document: 2 | Date: 2019-02-15

Therapy
- Initiated valganciclovir 900 mg PO BID, renally adjusted to 450 mg BID (CrCl ~55 mL/min).

Monitoring
- Weekly CMV PCR until two consecutive negatives, then monthly x3 months.
- Weekly CBC to monitor for leukopenia.

Plan
- Communicate with transplant nephrology re: monitoring. Consider reducing MMF if leukopenia develops.
